AEMPS recalls multiple batches of conjunctivitis eye drops due to quality defects

new health alert.Spanish Medicines and Health Products Agency drug defect detected Distributed in Spain. Specifically, it’s a medicine for conjunctivitis: eye drops. The agency had ordered the withdrawal on Aug. 30.

This is about keto brill, Brill Pharma Eye Drops

. There are multiple affected batches that are out of compliance. The specific reason for the withdrawal is “Reuse of sterile filters During its manufacture, this reuse was unproven.”

there are several lots They expire in 2023 and 2024.This is why all distributed units of the affected batch must qiut the market and return to the laboratory. recent, AEMPS

It also ordered the withdrawal of other drugs.

Which batches are affected?

have Three plots affected They must be withdrawn from the market immediately. details as follows:

• Batch: 21J004, expiry date 8/31/2023.
• Batch: 22C049, expiry date: February 28, 2024.
• Lot: 22D022, Expiry March 31, 2024.

AEMPS said the alert was a “quality defect, not life threatening for patients”, but these are not recommended.